Sartorius | SRT3 - Ebit


Sartorius reported EUR164M in EBIT for its fiscal quarter ending in June of 2026.





Ebit Change Date
Akebia Therapeutics USD -5.45M 9.4M Dec/2025
Alaunos Therapeutics USD -1.01M 175K Mar/2026
Avita Medical AUD -10.39M 1.72M Dec/2025
Dianthus Therapeutics USD -46.53M 23.01M Mar/2026
Ionis Pharmaceuticals USD -102.29M 15.71M Jun/2026
IQVIA Holdings USD 2.6B 2.03B Jun/2026
Moderna USD -815M 573M Jun/2026
Organon & Co USD 324M 351M Mar/2026
Revvity USD 126.14M 43.36M Jun/2026
Sartorius EUR 164M 3.3M Jun/2026
Tectonic Therapeutic USD -27.3M 5.78M Mar/2026
Viatris USD -20.2M 137.3M Mar/2026
Xeris Pharmaceuticals USD 9.12M 7.65M Mar/2026